| __timestamp | Bio-Techne Corporation | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 357763000 | 42237000000 |
| Thursday, January 1, 2015 | 452246000 | 39498000000 |
| Friday, January 1, 2016 | 499023000 | 39807000000 |
| Sunday, January 1, 2017 | 563003000 | 40122000000 |
| Monday, January 1, 2018 | 642993000 | 42294000000 |
| Tuesday, January 1, 2019 | 714006000 | 46840000000 |
| Wednesday, January 1, 2020 | 738691000 | 41518000000 |
| Friday, January 1, 2021 | 931032000 | 48704000000 |
| Saturday, January 1, 2022 | 1105599000 | 59283000000 |
| Sunday, January 1, 2023 | 1136702000 | 60115000000 |
| Monday, January 1, 2024 | 1159060000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and biotechnology industries, revenue growth is a key indicator of success. Over the past decade, Merck & Co., Inc. has consistently outpaced Bio-Techne Corporation in terms of annual revenue. From 2014 to 2023, Merck's revenue surged by approximately 42%, reaching a peak of $60 billion in 2023. In contrast, Bio-Techne's revenue grew by about 224% over the same period, yet it remains a fraction of Merck's, highlighting the scale difference between the two companies.
Merck's dominance is evident, with its revenue consistently exceeding $40 billion annually since 2014. Bio-Techne, while smaller, has shown impressive growth, with its revenue increasing from $358 million in 2014 to over $1.1 billion in 2023. This growth trajectory underscores Bio-Techne's potential in the biotech sector, despite the absence of 2024 data for Merck.
Johnson & Johnson and Merck & Co., Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Merck & Co., Inc. or Halozyme Therapeutics, Inc.?
Comparing Innovation Spending: Merck & Co., Inc. and Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Bio-Techne Corporation
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Breaking Down Revenue Trends: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Bio-Techne Corporation vs Telix Pharmaceuticals Limited
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Bio-Techne Corporation vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics